BioSpace News Archive

Deals

Hillstream BioPharma Announces Closing of Initial Public Offering

Hillstream BioPharma, Inc. announced the closing of its initial public offering of 3,750,000 shares of the Company’s common stock at a public offering price of $4.00 per share.

January 14, 2022
·
4 min read
Lone Star Bio

ISHLT Opens Registration for ISHLT2022 Annual Meeting and Scientific Sessions

The International Society for Heart and Lung Transplantation will host its 42nd Annual Meeting and Scientific Sessions on 27-30 April, 2022.

January 14, 2022
·
2 min read
Pharm Country

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Jan 14, 2022

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to five new employees.

January 14, 2022
·
3 min read
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares

China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC), today announced that it intends to offer in an underwritten public offering its ordinary shares and prefunded warrants to purchase ordinary shares.

January 14, 2022
·
4 min read
BioMidwest

Sun Nuclear Announces 2022 QA & Dosimetry Symposium (QADS) Program

Sun Nuclear Corporation, a wholly-owned subsidiary of Mirion Technologies, Inc., announced the full program for the 2022 QA & Dosimetry Symposium, April 8-9, in Orlando, Florida.

January 14, 2022
·
4 min read
Business

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, March 01, 2022

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2021 results on Tuesday, March 01, 2022.

January 14, 2022
·
1 min read